Kolexia
Massard Christophe Oncologie médicale
Massard Christophe
Oncologie médicale
Gustave-Roussy
Villejuif, France
1.5 K Activités
2 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Tumeurs prostatiques résistantes à la castration Métastase tumorale Carcinomes Tumeurs du poumon Néphrocarcinome Carcinome pulmonaire non à petites cellules Récidive tumorale locale Tumeurs du rein

Collaborateurs

Voir plus
Soria Jean-Charles
Soria Jean-Charles
Gustave-Roussy, Villejuif, France
Hollebecque Antoine
Hollebecque Antoine
Gustave-Roussy, Villejuif, France
Loriot Yohann
Loriot Yohann
Gustave-Roussy, Villejuif, France
Fizazi Karim
Fizazi Karim
Gustave-Roussy, Villejuif, France

Industries

Voir plus
Janssen
17 collaboration(s)
Dernière en 2023
MSD
6 collaboration(s)
Dernière en 2023
Roche
6 collaboration(s)
Dernière en 2023
AstraZeneca
5 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
IPATential150: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial Testing Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Asymptomatic or Mildly Symptomatic, Previously Untreated, Metastatic Castrate-Resistant Prostate Cancer
Essai Clinique (Roche)   13 mars 2024
RAGNAR: A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations
Essai Clinique (Janssen)   27 février 2024
AcSé: Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
Essai Clinique (Unicancer)   26 février 2024
A Score to Predict the Clinical Usefulness of Therapeutic Drug Monitoring: Application to Oral Molecular Targeted Therapies in Cancer.
Clinical pharmacology and therapeutics   23 février 2024
STARTER: A National, Multicenter, Phase III Randomized Controlled Trial to Assess the Impact of a One-year Supervised Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients
Essai Clinique (Centre Léon-Bérard)   20 février 2024
6O Subcutaneous fat mass predicts progression-free survival in patients treated with antibody drug conjugates in early phase clinical trials
Abstract Book of the ESMO Targeted Anticancer Therapies Congress (TAT) 26 - 28 February 2024   01 février 2024
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365): Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365)
Essai Clinique (Merck & Co.)   18 janvier 2024
Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA.
Experimental hematology & oncology   08 janvier 2024
The French National College of Oncology Teachers (CNEC): Missions, organization, and projects.
Bulletin du cancer   06 janvier 2024
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion: An Open Label, Phase 1, Treatment Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of IDE397 (MAT2A Inhibitor) In Adult Participants With Advanced Solid Tumors
Essai Clinique (IDEAYA Biosciences)   01 décembre 2023